EMILY WEBB: Open Payments
NPI 1669721007 · LAFAYETTE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 14 payments from 8 companies in 2025. Trend: 2023 $113 · 2024 $214 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $71 |
| Lilly USA, LLC | 2 | $43 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $17 |
| PFIZER INC. | 1 | $14 |
| Abbott Laboratories | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, JARDIANCE, GEMTESA, GVOKE HYPOPEN, The Cologuard Plus Collection Kit, NURTEC ODT, FREESTYLE LIBRE 3.
Industry payments across GA — which companies pay providers there.
